These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 14660450

  • 1. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.
    Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK.
    Br J Ophthalmol; 2003 Dec; 87(12):1453-8. PubMed ID: 14660450
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
    Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM, Aizman A.
    Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
    [Abstract] [Full Text] [Related]

  • 5. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L, Lin B, Hong J, Min HB, Han WL, Zhou TY, Zhang ZQ.
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [Abstract] [Full Text] [Related]

  • 9. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF.
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB, Mohr JK, Ossewaarde-van Norel A, den Hollander AI, Keunen JE, Hoyng CB, Boon CJ.
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [Abstract] [Full Text] [Related]

  • 16. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS.
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [Abstract] [Full Text] [Related]

  • 17. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
    Nicolò M, Zoli D, Musolino M, Traverso CE.
    Am J Ophthalmol; 2012 Mar; 153(3):474-480.e1. PubMed ID: 22019224
    [Abstract] [Full Text] [Related]

  • 18. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
    Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ.
    Am J Ophthalmol; 2003 Nov; 136(5):836-45. PubMed ID: 14597034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
    Roca JA, Wu L, Fromow-Guerra J, Rodríguez FJ, Berrocal MH, Rojas S, Lima LH, Gallego-Pinazo R, Chhablani J, Arevalo JF, Lozano-Rechy D, Serrano M.
    Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.